本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neumora Therapeutics, Inc.

1.93
-0.4000-17.17%
盘后1.940.0100+0.52%16:13 EDT
成交量:277.21万
成交额:552.55万
市值:3.28亿
市盈率:-1.32
高:2.15
开:2.15
低:1.82
收:2.33
52周最高:3.65
52周最低:0.6110
股本:1.70亿
流通股本:8,606.30万
量比:3.60
换手率:3.22%
股息:- -
股息率:- -
每股收益(TTM):-1.4632
每股收益(LYR):-1.5296
净资产收益率:-104.35%
总资产收益率:-56.71%
市净率:2.48
市盈率(LYR):-1.26

数据加载中...

2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/11

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

重要事件披露

Form 8-K - Current report
2024/11/22

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors